Chemokines and their receptors play a critical role in orchestrating the immune response during experimental autoimmune encephalomyelitis (EAE). Expression of CCR4 and its ligand CCL22 has been observed in ongoing disease. Here we describe a role for CCR4 in EAE, illustrating delayed and decreased disease incidence in CCR4 −/− mice corresponding with diminished CNS infiltrate. Peripheral T cell responses were unaltered in CCR4 −/− mice; rather, disease reduction was related to reduced CD11b + Ly6C hi inflammatory macrophage (iMϕ) numbers and function. These results provide evidence that CCR4 regulates EAE development and further supports the involvement of CCR4 in iMϕ effector function.
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Introduction
Experimental autoimmune encephalomyelitis (EAE) is a T helper cell mediated autoimmune disease of the central nervous system (CNS) that shares many disease characteristics with multiple sclerosis (MS) (Hickey, 1999) . The disease manifests itself clinically as ascending hind limb paralysis, induced by immunization with myelin antigen emulsified in complete Freund's adjuvant (CFA) or encephalitogenic CD4 + T cell transfer (Whitham et al., 1991; Baron et al., 1993; Bettelli et al., 2003) . This results in infiltration of mononuclear cells, including but not limited to; CD4 + T cells, CD8 + T cells, macrophages (Mϕ) and dendritic cells (DC) into the spinal cord resulting in inflammation and demyelination (Brosnan et al., 1981; Hickey et al., 1983; Jensen et al., 1992; Abdul-Majid et al., 2003; Bailey et al., 2007) . Chemokines are small molecular weight chemoattractants that are produced under steady state and pathological conditions to maintain or influence cell recruitment to specific tissues (Karpus et al., 1995; Huang et al., 2001; Forster et al., 2008) . Chemokines can function in differentiation and maturation of leukocytes, in addition to their well described role in cell trafficking and accumulation (Karpus et al., 1997; Marsland et al., 2005) . Various chemokines and their cognate receptors are expressed during EAE, and have been shown to be important for disease progression (Karpus and Kennedy, 1997; Fife et al., 2000; Rottman et al., 2000; Fife et al., 2001; Huang et al., 2001; Carlson et al., 2008; Elhofy et al., 2009; Dogan et al., 2011) . CCR4 and CCL22 transcripts are known to be expressed in the CNS of mice during EAE (Columba-Cabezas et al., 2002) . Recently, we demonstrated inhibition of CCL22 ameliorated EAE in SJL mice by reducing the CNS accumulation of the inflammatory macrophage (iMϕ) population and/or reducing the inflammatory function of that cellular population (Dogan et al., 2011) .
In the present study, we sought to distinguish between these two possibilities by utilizing CCR4 −/− mice to determine whether CCR4
regulates iMϕ tissue accumulation or inflammatory function. Macrophages are critical for the development of EAE, as evidenced by depletion studies which resulted in greatly diminished disease (Huitinga et al., 1993 
